You are here:

Category: 9.1 Anaemias and some other blood disorders

Name SMC ID No Manufacturer Status Sub. Type
 
Anagrelide 0.5mg capsule (Xagrid®) 163/05 Shire Pharmaceuticals Accepted Resubmission
Anagrelide 0.5mg capsule (Xagrid®) 163/05 Shire Pharmaceuticals Not Recommended Full submission
Darbepoetin alfa Sureclick (Aranesp) 265/06 Amgen Ltd Superseded Non submission
Darbepoetin alfa (Aranesp®) 273/06 Amgen Ltd Superseded Non submission
deferasirox (Exjade) 866/13 Novartis Pharmaceuticals UK Ltd Not Recommended Non submission
deferasirox (Exjade) 347/07 Novartis Pharmaceuticals UK Ltd Restricted Full submission
deferasirox (Exjade) 347/07 Novartis Pharmaceuticals UK Ltd Restricted Resubmission
eculizumab (Soliris) 767/12 Alexion Pharma UK Ltd Not Recommended Non submission
eculizumab (Soliris) 915/13 Alexion Pharma UK Ltd Not Recommended Non submission
eculizumab (Soliris) 436/07 Alexion Pharma UK Ltd Not Recommended Non submission
eculizumab (Soliris) 436/07 Alexion Pharma UK Ltd Not Recommended Full submission
eculizumab (Soliris) aHUS 767/12 Alexion Pharma UK Ltd Not Recommended Full submission
eculizumab (Soliris) for PNH 1130/16 Alexion Pharma UK Ltd Not Recommended Full submission
eltrombopag (Revolade) 1206/17 Novartis Pharmaceuticals UK Ltd Restricted Abbreviated Submission
eltrombopag (Revolade) 919/13 GlaxoSmithKline UK Ltd Accepted Full submission
eltrombopag olamine (Revolade) 1164/16 Novartis Pharmaceuticals UK Ltd Not Recommended Non submission
epoetin alfa (Binocrit) 597/10 Sandoz Ltd Accepted Full submission
epoetin delta prefilled syringe (Dynepo) 418/07 Shire Pharmaceuticals Marketing Authorisation Withdrawn Full submission
epoetin theta (Eporatio) 620/10 Ratiopharm UK Accepted Full submission
epoetin zeta (Retacrit) 467/08 Hospira UK Limited Accepted Full submission
ferric carboxymaltose (Ferinject) 463/08 Syner-Med (PP) Ltd Not Recommended Full submission
ferric carboxymaltose (Ferinject) 463/08 Vifor Pharma Not Recommended Resubmission
ferric carboxymaltose (Ferinject) 463/08 Vifor Pharma Restricted Resubmission
ferric maltol (Feraccru) 1202/16 Shield Therapeutics Not Recommended Full submission
ferumoxytol (Rienso) 833/13 Takeda UK Ltd Marketing Authorisation Withdrawn Full submission
filgrastim (Nivestim) 671/11 Hospira UK Limited Accepted Full submission
filgrastim (Ratiograstim) 577/09 Ratiopharm UK Accepted Full submission
filgrastim (TevaGrastim) 629/10 Teva UK Limited Accepted Abbreviated Submission
filgrastim (Zarzio) 704/11 Sandoz Ltd Accepted Full submission
hydroxycarbamide (Siklos) 582/09 Nordic Pharma UK Not Recommended Non submission
iron (III) isomaltoside 1000 (Diafer) 1177/16 Pharmacosmos UK Accepted Resubmission
iron (III) isomaltoside 1000 (Diafer) 1177/16 Pharmacosmos UK Not Recommended Full submission
iron isomaltoside 100mg/ml (Monofer) 697/11 Pharmacosmos UK Restricted Full submission
lipegfilgrastim, 6mg, solution for injection (Lonquex®) 908/13 Teva UK Limited Restricted Full submission
Methoxy polyethylene glycol-epoetin beta 455/08 Roche Accepted Full submission
Pegfilgrastim (Neulasta®) 67/03 Amgen Ltd Restricted Full submission
plerixafor (Mozobil) 594/09 Genzyme Therapeutics Ltd Accepted Full submission
romiplostim (Nplate) 553/09 Amgen Ltd Restricted Full submission

Back